REFRACTORY LUPUS NEPHRITIS
Clinical trials for REFRACTORY LUPUS NEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY LUPUS NEPHRITIS trials appear
Sign up with your email to follow new studies for REFRACTORY LUPUS NEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell therapy shows promise for Tough-to-Treat lupus and scleroderma
Disease control Recruiting nowThis study is testing a new treatment using specially engineered immune cells (CAR T cells) from donated cord blood for people with severe lupus, scleroderma, or Sjogren's syndrome that hasn't improved with standard treatments. The main goal is to check if the therapy is safe and…
Matched conditions: REFRACTORY LUPUS NEPHRITIS
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
Engineered immune cells target three tough autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment using a patient's own immune cells, modified to target and destroy harmful cells in three severe autoimmune conditions: lupus nephritis, systemic sclerosis, and Sjogren's syndrome with pulmonary hypertension. About 45 adults will receive a single …
Matched conditions: REFRACTORY LUPUS NEPHRITIS
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
15-Year safety check for experimental CAR t therapy begins
Knowledge-focused Recruiting nowThis study tracks 70 people who have already received an infusion of KYV-101, a CAR T cell therapy, for autoimmune diseases like lupus, multiple sclerosis, and rheumatoid arthritis. The goal is to watch for delayed side effects, new cancers, or other health problems over up to 15…
Matched conditions: REFRACTORY LUPUS NEPHRITIS
Sponsor: Kyverna Therapeutics • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC